Inventiva Company Top Insiders
| IVEVF Stock | USD 3.64 0.00 0.00% |
Inventiva employs about 109 people. The company is managed by 8 executives with a total tenure of roughly 255 years, averaging almost 31.0 years of service per executive, having 13.63 employees per reported executive. Examination of Inventiva's management performance can provide insight into the company performance.
| Frederic Cren CEO CEO, Co-Founder |
Inventiva |
Inventiva Management Team Effectiveness
The company has return on total asset (ROA) of (0.3438) % which means that it has lost $0.3438 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7073) %, meaning that it generated substantial loss on money invested by shareholders. Inventiva's management efficiency ratios could be used to measure how well Inventiva manages its routine affairs as well as how well it operates its assets and liabilities.Inventiva Workforce Comparison
Inventiva SA is currently regarded as number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 92,710. Inventiva adds roughly 109 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
Inventiva SA Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Inventiva SA Price Series Summation is a cross summation of Inventiva price series and its benchmark/peer.
Inventiva Notable Stakeholders
An Inventiva stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Inventiva often face trade-offs trying to please all of them. Inventiva's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Inventiva's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Pierre Broqua | Co-Founder, Chief Scientific Officer | Profile | |
| Frederic Cren | CEO, Co-Founder | Profile | |
| Jean Volatier | Chief Officer | Profile | |
| Eric LLM | G Counsel | Profile | |
| JeanPaul MD | Head Pharmacovigilance | Profile | |
| Michael Cooreman | Chief Officer | Profile | |
| Irena Konstantinova | Head of Fibrosis Research | Profile | |
| Nathalie Harroy | Head of Human Resources | Profile |
About Inventiva Management Performance
The success or failure of an entity such as Inventiva SA often depends on how effective the management is. Inventiva management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Inventiva management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Inventiva management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis , mucopolysaccharidoses , and other diseases. Inventiva S.A. was founded in 2011 and is based in Daix, France. Inventiva is traded on OTC Exchange in the United States.
Inventiva Workforce Analysis
Traditionally, organizations such as Inventiva use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Inventiva within its industry.Inventiva Manpower Efficiency
Return on Inventiva Manpower
| Revenue Per Employee | 38.5K | |
| Revenue Per Executive | 524.2K | |
| Net Loss Per Employee | 455.4K | |
| Net Loss Per Executive | 6.2M |
Complementary Tools for Inventiva Pink Sheet analysis
When running Inventiva's price analysis, check to measure Inventiva's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inventiva is operating at the current time. Most of Inventiva's value examination focuses on studying past and present price action to predict the probability of Inventiva's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inventiva's price. Additionally, you may evaluate how the addition of Inventiva to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |